(Q73814544)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341603%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

A comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341603%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

I I Müderris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341603%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F Bayram

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341603%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Y Sahin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341603%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F Keleştimur

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341603%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 October 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341603%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341603%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341603%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341603%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

644-647

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341603%20AND%20SRC:MED&resulttype=core&format=json

Hirsutism. Practical therapeutic guidelines

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

Idiopathic Hirsutism — An Ovarian Abnormality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

Treatment of hirsutism with the pure antiandrogen flutamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

Effects of flutamide and aminoglutethimide on plasma 5 alpha-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

The use of antiandrogen flutamide in the treatment of hirsutism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

Treatment of hirsutism in women with flutamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial**Supported in part by Schering-Plough, Pointe-Claire, Québec, Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

Comparison of the efficacy of spironolactone**Spironolactone (Aldactone; Searle, Chicago, IL). versus flutamide††Flutamide (Eulexin; Schering Plough Laboratories, Heist, Belgium). in the treatment of hirsutism‡‡Presented in part at the 3rd Wo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

Effects of flutamide, a pure antiandrogen, on endocrine parameters, in the adult female rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

The impact of a pure anti-androgen (flutamide) on LH, FSH, androgens and clinical status in idiopathic hirsutism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2897%2900266-5

10.1016/S0015-0282(97)00266-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9341603%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference